Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene

Annals of Neurology

Volumn 49, Issue 3, 2001, Pages 367-376

  Hilker, Ruediger ^a   Klein, Christine ^b   Ghaemi, Mehran ^b   Kis, Bernhard ^c   Strotmann, Tim ^d   Ozelius, Laurie J ^e   Lenz, Olaf ^a   Vieregge, Peter ^b   Herholz, Karl ^b   Heiss, Wolf Dieter ^a   Pramstaller, Peter P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^e General Regional Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; FEMALE; GENE MUTATION; HUMAN; ITALY; MALE; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; ANALYSIS OF VARIANCE; CORPUS STRIATUM; FEMALE; HUMANS; LIGASES; MALE; MIDDLE AGED; MUTATION; PARKINSONIAN DISORDERS; PEDIGREE; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED; UBIQUITIN-PROTEIN LIGASES;

EID: 0035096967     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.74     Document Type: Article

References (40)

1. Mutation in the α-synuclein gene identified in families with Pakinson's disease
2. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
3. A susceptibility locus for Parkinson's disease maps to chromosome 2p13
4. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
5. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe
6. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
7. Association between early-onset Parkinson's disease and mutations in the parkin gene
8. Parkin deletions in a family with adult-onset, tremor dominant parkinsonism: Expanding the phenotype
9. The clinical genetics of Parkinsons's disease
10. Genetic factors in the eriology of idiopathic Parkinson's disease
11. Human positron emission tomographic [18F] fluorodopa studies correlate with dopamine cell counts and levels
12. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography
13. PET studies of parkinsonism associated with mutation in the alpha-synuclein gene
14. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
15. Parkinsonism: Onset, progression and mortality
16. Unified Parkinson's disease rating scale
17. The ECAT EXACT HR: Performance of a new high resolution positron scanner
18. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data: Generalizations
19. 11C-labeled raclopride in rat striatum using positron emission tomography
20. Simplified reference tissue model for PET receptor studies
21. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
22. Ageing and Parkinson's disease: Substantia nigra regional selectivity
23. 18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate
24. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
25. Dopa metabolism
26. 18F]dopa positron emission tomography
27. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydroxylase 1 gene
28. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with doparesponsive dystonia
29. Levodopa-responsive dystonia, GTP Cyclohydroxylase I or parkin mutations?
30. 11C]-raclopride and positronemission-tomography
31. 2 receptor binding in dopa-responsive dystonia
32. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease
33. Complementary emission tomographic studies of the striatal dopaminergic system in Parkinson's disease
34. Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism
35. Nigrostriatal damage is requited for induction of dyskinesias by L-dopa in squirrel monkeys
36. 11C]-raclopride in the human brain
37. PET measures amphetamine-induced dopamine release in ventral versus dorsal striatum
38. Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits
39. Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study
40. Investigation of the nigrostriatal dopaminergic system in two brothers with autosomal recessive young-onset parkinsonism